Coagulation factor VIIa (also known as Activated Factor VII or FVIIa) is a man-made form of a protein found in the body. It's used to treat certain types of bleeding in people with hemophilia A or B who have developed inhibitors. It works by stimulating the body's natural clotting process to help stop or reduce bleeding. Coagulation factor VIIa is given as an injection directly into a vein (IV) or muscle (IM).
Coagulation Factor VIIa (rFVIIa)
Coagulation factor VIIa (rFVIIa), also known as recombinant activated factor VII, is a lab-made form of activated factor VII, a protein naturally produced in the liver that plays a crucial role in the blood clotting process.
Here's a deeper look at rFVIIa:
Function:
- Similar to natural factor VIIa: Like its naturally occurring counterpart, rFVIIa triggers and amplifies the clotting cascade, ultimately leading to the formation of a blood clot.
- More potent than natural factor VII: Unlike natural factor VII, rFVIIa is already in its activated form, making it more potent and faster-acting in initiating the clotting process.
Medical uses:
- Treating and preventing bleeding in individuals with deficiencies: This includes:
- Congenital factor VII deficiency: A rare genetic disorder where the body doesn't produce enough factor VII.
- Acquired factor VII deficiency: This can occur due to liver disease, vitamin K deficiency, or certain medications.
- Treatment of bleeding episodes in specific situations:
- Hemophilia A or B with inhibitors: When individuals with these bleeding disorders develop antibodies that block the effectiveness of other clotting factor replacement therapies (e.g., factor VIII or IX).
- Severe uncontrolled bleeding during surgery or trauma: In some cases, rFVIIa can be used as an additional treatment to promote clot formation.
Important considerations:
- Not a first-line treatment: rFVIIa is typically not the first-line treatment for most bleeding disorders due to:
- High cost: rFVIIa is an expensive medication.
- Potential for side effects: rFVIIa can cause serious side effects, including:
- Blood clots: This is a major concern, as rFVIIa promotes clot formation, and inappropriate clotting can lead to serious complications like stroke, heart attack, or pulmonary embolism (blood clot in the lung).
- Allergic reactions: While rare, allergic reactions can occur.
- Off-label use: While rFVIIa is approved for specific indications, it may be used off-label by healthcare professionals in certain situations based on their clinical judgment.
It is crucial to consult with a healthcare professional for proper diagnosis and treatment if you have concerns about bleeding disorders or suspect a factor VII deficiency. They can assess your individual needs and determine the most appropriate course of treatment, considering the potential benefits and risks of rFVIIa and other options.